Drug major Ranbaxy Laboratories could suffer a potential revenue loss to the tune of Rs 300 crore (Rs 3 billion) due to delay in receiving approval from the US Food and Drug Administration (FDA) for generic version of GSK's anti-migraine medicine Imitrex, according to analysts.

Drug major Ranbaxy Laboratories could suffer a potential revenue loss to the tune of Rs 300 crore due to delay in receiving approval from the USFDA for generic version of GSK's anti-migraine medicine Imitrex.

NEW DELHI: Drug major Ranbaxy Laboratories could suffer a potential revenue loss to the tune of Rs 300 crore due to delay in receiving approval from the US Food and Drug Administration (FDA) for generic version of GSK's anti-migraine medicine Imitrex, according to analysts.

Inside the heads of a staggering 30 million Americans is a place migraines love to call home. Learning to manage the pain and prevent onset is the best defense against these intense headaches.

(By Linda A. Johnson, Associated Press) Finally, a little good health care news for consumers: U.S. prices for generic prescription drugs, which already cost as little as one-third of their brand-name cousins, have been getting cheaper and likely will keep doing so. The causes? The ultra-low prices for generic prescriptions offered by giant retailers and drugstore chains and intense competition ...

U.S. prices for generic prescription drugs, which already cost as little as one-third what their brand-name cousins do, have been getting cheaper and likely will keep doing so.

People have long thought that anything in excess can be a bad thing. Add narcotics and barbituates to the list. Besides the obvious problem of addiction, researchers at the Albert...

Published: Wednesday, October 29, 2008 at 11:10 a.m. Last Modified: Wednesday, October 29, 2008 at 12:51 p.m. The high cost of prescription drugs is a concern for almost everyone. Even for people fortunate enough to have prescription drug insurance, costs can add up quickly.

We all know headaches are quite a concern, so it's not surprising to find that headaches are a global problem. Specifically, international researchers are calling for more investigation into effective...

NEW YORK----Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.